Takeda (TAK) - Management Comments

Takeda (TAK) – Management Comments

Dec 4, 2020 09:02 AM Y-mAbs Therapeutics (YMAB), Takeda (TAK) Announce Exclusive License and Distribution Agreement for DANYELZA® (naxitamab-gqgk) and Omburtamab in Israel
Oct 7, 2020 06:33 AM Kamada Ltd. (KMDA) Provides Update on 2021 GLASSIA Supply to Takeda (TAK)
Aug 7, 2020 06:18 AM
Jun 16, 2020 07:02 AM
Jun 11, 2020 07:11 AM
May 22, 2020 04:31 PM
May 14, 2020 08:07 AM
Apr 6, 2020 08:03 AM
Mar 31, 2020 08:10 AM
Mar 10, 2020 08:01 AM
Mar 2, 2020 06:09 AM
Feb 26, 2020 05:59 AM
Sep 25, 2019 05:02 PM
Sep 24, 2019 07:06 AM
Jun 5, 2019 05:08 PM
Jun 3, 2019 09:02 AM
Dec 18, 2018 05:35 PM